Predictability of lymph node involvement in uterus-confined endometrioid endometrial cancer by tumour size, pattern and location measured with transvaginal ultrasonography: can we save time?

References

• AlHilli MM, Podratz KC, Dowdy SC, Bakkum-Gamez JN, Weaver AL, McGree ME, et al. 2013. Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer. Gynecologic Oncology 131:103–108.
   PubMed Web of Science ®Google Scholar
• AlHilli MM, Mariani A. 2014. Preoperative selection of endometrial cancer patients at low risk for lymph node metastases: useful criteria for enrollment in clinical trials. Journal of Gynecologic Oncology 25:267.
   PubMed Web of Science ®Google Scholar
• ASTEC Study Group, Kitchener H, Swart AMC, Qian Q, Amos C, Parmar MKB. 2009. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373:125–136.
   PubMed Web of Science ®Google Scholar
• Berretta R, Merisio C, Piantelli G, Rolla M, Giordano G, Melpignano M, et al. 2008. Preoperative transvaginal ultrasonography and intraoperative gross examination for assessing myometrial invasion by endometrial cancer. Journal of Ultrasound in Medicine 27:349–355.
   PubMed Web of Science ®Google Scholar
• Berretta R, Patrelli TS, Migliavacca C, Rolla M, Franchi L, Monica M, et al. 2014. Assessment of tumor size as a useful marker for the surgical staging of endometrial cancer. Oncology Reports 31:2407–2412.
   PubMed Web of Science ®Google Scholar
• Brown A, Madom L, Moore R, Granai C, Disilvestro P. 2007. The prognostic significance of lower uterine segment involvement in surgically staged endometrial cancer patients with negative nodes. Gynecologic Oncology 105:55–58.
   PubMed Web of Science ®Google Scholar
• Capozzi VA, Sozzi G, Rosati A, Restaino S, Gambino G, Cianciolo A, et al. 2022. Predictive score of nodal involvement in endometrial cancer patients: a large, multicenter series. Annals of Surgical Oncology 29:2602–2602.
   PubMed Web of Science ®Google Scholar
• Chattopadhyay S, Cross P, Nayar A, Galaal K, Naik R. 2013. Tumor size: a better independent predictor of distant failure and death than depth of myometrial invasion in International Federation of Gynecology and Obstetrics stage I endometrioid endometrial cancer. International Journal of Gynecological Cancer 23:690–697.
   PubMed Web of Science ®Google Scholar
• Clement PB, Young RH. 2002. Endometrioid carcinoma of the uterine corpus: a review of its pathology with emphasis on recent advances and problematic aspects. Advances in Anatomic Pathology 9:145–184.
   PubMed Web of Science ®Google Scholar
• Colombo N, Creutzberg C, Amant F, Bosse T, González-Martín A, Ledermann J, et al. 2016. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Annals of Oncology 27:16–41.
   PubMed Web of Science ®Google Scholar
• Concin N, et al. 2021. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. International Journal of Gynecological Cancer 31:12–39.
   PubMed Web of Science ®Google Scholar
• Convery PA, Cantrell LA, Di Santo N, Broadwater G, Modesitt SC, Secord AA, et al. 2011. Retrospective review of an intraoperative algorithm to predict lymph node metastasis in low-grade endometrial adenocarcinoma. Gynecologic Oncology 123:65–70.
   PubMed Web of Science ®Google Scholar
• Creasman W. 2009. Revised FIGO staging for carcinoma of the endometrium. International Journal of Gynecology and Obstetrics 105:109.
   PubMed Web of Science ®Google Scholar
• Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB, et al. 1987. Surgical pathologic spread patterns of endometrial cancer: a gynecologic oncology group study. Cancer 60:2035–2041.
   PubMed Web of Science ®Google Scholar
• Cusimano MC, Vicus D, Pulman K, Maganti M, Bernardini MQ, Bouchard-Fortier G, et al. 2021. Assessment of sentinel lymph node biopsy vs lymphadenectomy for intermediate- and high-grade endometrial cancer staging. JAMA Surgery 156:157.
   PubMed Web of Science ®Google Scholar
• Eriksson LSE, Epstein E, Testa AC, Fischerova D, Valentin L, Sladkevicius P, et al. 2020. Ultrasound-based risk model for preoperative prediction of lymph-node metastases in women with endometrial cancer: model-development study. Ultrasound in Obstetrics and Gynecology 56:443–452.
   PubMed Web of Science ®Google Scholar
• Euscher E, Fox P, Bassett R, Al-Ghawi H, Ali-Fehmi R, Barbuto D, et al. 2013. The pattern of myometrial invasion as a predictor of lymph node metastasis or extrauterine disease in low-grade endometrial carcinoma. American Journal of Surgical Pathology 37:1728–1736.
   PubMed Web of Science ®Google Scholar
• Frost JA, Webster KE, Bryant A, Morrison J. 2017. Lymphadenectomy for the management of endometrial cancer. Cochrane Database of Systematic Reviews 10:CD007585.
   PubMed Web of Science ®Google Scholar
• Hachisuga T, Kaku T, Enjoji M. 1989. Carcinoma of the lower uterine segment: clinicopathologic analysis of 12 cases. International Journal of Gynecological Pathology 8:26–35.
   PubMed Web of Science ®Google Scholar
• Koskas M, Rouzier R, Amant F. 2015. Staging for endometrial cancer: the controversy around lymphadenectomy – can this be resolved? Best Practice and Research: Clinical Obstetrics and Gynaecology 29:845–857.
   PubMed Web of Science ®Google Scholar
• Lee J, Kong T-W, Paek J, Chang S-J, Ryu H-S. 2016. Predicting model of lymph node metastasis using preoperative tumor grade, transvaginal ultrasound, and serum CA-125 level in patients with endometrial cancer. International Journal of Gynecological Cancer 26:1630–1635.
   PubMed Web of Science ®Google Scholar
• Li Y, Cong P, Wang P, Peng C, Liu M, Sun G, et al. 2019. Risk factors for pelvic lymph node metastasis in endometrial cancer. Archives of Gynecology and Obstetrics 300:1007–1013.
   PubMed Web of Science ®Google Scholar
• Malpica A, Euscher ED, Hecht JL, Ali-Fehmi R, Quick CM, Singh N, et al. 2019. Endometrial carcinoma, grossing and processing issues: recommendations of the International Society of Gynecologic Pathologists. International Journal of Gynecological Pathology 38:S9–S24.
   PubMed Web of Science ®Google Scholar
• Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G, Podratz KC, et al. 2000. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? American Journal of Obstetrics and Gynecology 182:1506–1519.
   PubMed Web of Science ®Google Scholar
• Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO, et al. 2008. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecologic Oncology 109:11–18.
   PubMed Web of Science ®Google Scholar
• Panici PB, Basile S, Maneschi F, Lissoni AA, Signorelli M, Scambia G, et al. 2008. Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. Journal of the National Cancer Institute 100:1707–1716.
   PubMedGoogle Scholar
• Schink JC, Lurain JR, Wallemark CB, Chmiel JS. 1987. Tumor size in endometrial cancer: a prognostic factor for lymph node metastasis. Obstetrics and Gynecology 70:216–219.
   PubMed Web of Science ®Google Scholar
• Selman TJ, Mann CH, Zamora J, Khan KS. 2008. A systematic review of tests for lymph node status in primary endometrial cancer. BMC Women's Health 8:8.
   PubMedGoogle Scholar
• Tuomi T, Pasanen A, Luomaranta A, Leminen A, Bützow R, Loukovaara M, et al. 2015. Risk-stratification of endometrial carcinomas revisited: a combined preoperative and intraoperative scoring system for a reliable prediction of an advanced disease. Gynecologic Oncology 137:23–27.
   PubMed Web of Science ®Google Scholar